Mainstreaming Addiction Treatment (MAT) Act Signed into Law

The Mainstreaming Addiction Treatment (MAT) Act was signed into law on December 29, 2022. This legislation removes the requirement for providers to complete training and/or obtain an X-waiver to prescribe buprenorphine for the treatment of opioid use disorder. It also removes the patient limit per prescriber. For more information, please review this summary.

Topic:

Medications for Addiction Treatment (MAT),  Policy,  

Keyword Tags:

  • buprenorphine
  • legislation
  • MAT
  • work icon